[New genetic concepts in manic-depressive psychosis].
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000453:epidemiology / Q000235:genetics* / Q000378:metabolism; D001789:Blood Group Antigens; D001923:Brain Chemistry; D002648:Child; D003117:Color Vision Defects / Q000235:genetics; D004200:Diseases in Twins; D005089:Exocytosis; D005190:Family; D005260:Female; D005799:Genes, Dominant; D005838:Genotype; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010375:Pedigree; D010507:Periodicity; D011995:Recombination, Genetic; D012701:Serotonin / Q000378:metabolism; D012730:Sex Chromosomes; D009435:Synaptic Transmission
D000928:Antidepressive Agents; D001789:Blood Group Antigens; D012701:Serotonin; D008094:Lithium; D008995:Monoamine Oxidase; D009638:Norepinephrine
Nouvelles conceptions génétiques sur la psychose maniaco-dépressive.